Regeneron Pharmaceuticals
The Director, Contract Strategy at Regeneron leads account-focused contracting strategy for IDNs, GPOs, and payers within the Ophthalmology portfolio. The role focuses on shaping pricing and contracting approaches, developing analytical frameworks and financial scenarios, and partnering cross-functionally to align contract programs with company and compliance requirements.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Principal Contract Analyst- CV Offer Development
Medtronic
Analyst, Contract Marketing (IV Therapy)
Fresenius Kabi
Manager, Contract Negotiations
Fresenius Kabi
Sr Analyst, Contract Marketing (Contract Compliance)
Fresenius Kabi
Director, Contract Strategy
Pfizer
Senior Analyst, Contract Marketing
Fresenius Kabi